12:00 AM
 | 
May 07, 2012
 |  BC Week In Review  |  Company News  |  Deals

Fougera, Novartis deal

Novartis' Sandoz Ltd. generics unit will acquire dermatology generics company Fougera for $1.5 billion in cash. Fougera (formerly Nycomed US Inc.) was the U.S. dermatology subsidiary of Nycomed before it became a standalone company following...

Read the full 175 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >